Skip to Content

Proposed Rule

Hematology and Pathology Devices; Reclassification of Automated Differential Cell Counters; Correction

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Proposed rule; correction.

SUMMARY:

The Food and Drug Administration (FDA) is correcting a proposed rule that appeared in the Federal Register of May 9, 2001 (66 FR 23634). The document proposes to reclassify from class III (premarket approval) to class II (special controls) the automated differential cell counter (ADCC). The document published inadvertently with the incorrect docket number. This document corrects that error.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Joyce Strong, Office of Policy, Planning, and Legislation (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In FR Doc. 01-11580, appearing in the Federal Register of Wednesday, May 9, 2001, the following correction is made: On page 23634, in the second column, “[Docket No. 95P-0351]” is corrected to read “[Docket No. 95P-0315].”

Start Signature

Dated: July 17, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 01-18343 Filed 7-20-01; 8:45 am]

BILLING CODE 4160-01-S